GIRALDI, TULLIO
 Distribuzione geografica
Continente #
NA - Nord America 7.534
AS - Asia 3.131
EU - Europa 2.603
SA - Sud America 272
Continente sconosciuto - Info sul continente non disponibili 159
AF - Africa 106
OC - Oceania 2
Totale 13.807
Nazione #
US - Stati Uniti d'America 7.480
SG - Singapore 1.223
CN - Cina 898
SE - Svezia 593
UA - Ucraina 564
IT - Italia 330
HK - Hong Kong 251
VN - Vietnam 241
BR - Brasile 218
KR - Corea 216
FI - Finlandia 191
FR - Francia 153
TR - Turchia 143
GB - Regno Unito 136
RU - Federazione Russa 108
DE - Germania 99
PL - Polonia 95
BG - Bulgaria 84
IE - Irlanda 81
MA - Marocco 80
CH - Svizzera 51
NL - Olanda 42
IN - India 31
BD - Bangladesh 29
BE - Belgio 23
CA - Canada 23
AR - Argentina 22
JP - Giappone 13
MX - Messico 12
ID - Indonesia 11
IQ - Iraq 10
EC - Ecuador 9
MK - Macedonia 9
CZ - Repubblica Ceca 8
ES - Italia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PK - Pakistan 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
EU - Europa 5
HR - Croazia 5
MY - Malesia 5
PH - Filippine 5
RO - Romania 5
SN - Senegal 5
ZA - Sudafrica 5
BO - Bolivia 4
IL - Israele 4
JO - Giordania 4
TH - Thailandia 4
TW - Taiwan 4
EG - Egitto 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
PA - Panama 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
IM - Isola di Man 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
Totale 13.655
Città #
Ann Arbor 826
Woodbridge 756
Singapore 743
Fairfield 612
Houston 568
Ashburn 554
Jacksonville 475
San Jose 424
Chandler 410
Wilmington 316
Seattle 280
Hong Kong 248
Hefei 233
Beijing 224
Cambridge 213
Seoul 213
Princeton 158
Council Bluffs 156
Columbus 155
Boardman 138
Izmir 121
Chicago 106
Sofia 84
Dublin 81
Casablanca 79
Zgierz 77
Ho Chi Minh City 75
Moscow 75
Lauterbourg 72
Milan 69
Buffalo 64
The Dalles 62
Dallas 58
Los Angeles 58
Hanoi 57
Bern 48
Santa Clara 42
San Diego 36
Düsseldorf 33
Dearborn 26
Helsinki 26
Phoenix 26
Des Moines 25
Frankfurt am Main 23
Jinan 23
Bremen 22
Brussels 22
New York 22
Guangzhou 17
Shenyang 17
Norwalk 16
Verona 15
São Paulo 14
Warsaw 14
London 13
Nanjing 13
Shanghai 13
Tianjin 13
Tokyo 12
Brooklyn 11
Kocaeli 11
Kunming 11
Miano 11
Trieste 11
Atlanta 10
Falls Church 10
Haiphong 10
Da Nang 9
Redondo Beach 9
Skopje 9
Edinburgh 8
Mestre 8
Orem 8
Brasília 7
Chennai 7
Denver 7
Detroit 7
Fremont 7
Fuzhou 7
Manchester 7
Munich 7
Rio de Janeiro 7
Tashkent 7
Turku 7
Washington 7
Auburn Hills 6
Montreal 6
San Francisco 6
Toronto 6
Baghdad 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Catania 5
Dakar 5
Hebei 5
Jakarta 5
Jiaxing 5
Manaus 5
Nanchang 5
Totale 9.670
Nome #
Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. 273
Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. 258
Antihypertensive activity of arylidenaminoguanidine derivatives. 248
5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients. 240
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms 239
Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichloro-diamminoplatinum(II) in mice bearing Lewis lung carcinoma 239
Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. 233
Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. 231
Mental adaptation to cancer: depression and blood platelet monoamine oxidase activity in breast cancer patients 228
Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells 225
Antitumor and antimetastatic effects of benzenoid triazenes in mice bearing Lewis lung carcinoma. 222
Antimetastatic action of the prostacyclin analog Iloprost in the mouse 222
Spermatic toxicity of Diazoacetyl-glycine amide (DGA) in mice. 219
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 215
Biochemical and biological characteristics of leucocyte proteinase inhibitors. 213
Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice. 211
Stress and chemotherapy. Combined effects on tumor progression and immunity in animal models 210
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 209
Antimetastatic effects and tumor proteinase inhibition by spleen intracellular inhibitors of neutral proteinases. 207
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 206
Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart 205
5-HTTLPR POLYMORPHISM OF SEROTONIN TRANSPORTER AND EFFECTS OF SERTRALINE IN TERMINALLY ILL CANCER PATIENTS: REPORT OF ELEVEN CASES 205
Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice. 203
Methodologic problems encountered in the assay of proteinases in Lewis lung carcinoma, a mouse metastasizing tumor. 203
Antitumor action of rhodium(I) and iridium(I) complexes 203
Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. 201
Blockers of adrenergic neurons and receptors, tumor progression and effects of rotational stress in mice. 196
An early structured psychoeducational intervention in patients with breast cancer. 192
Investigation on the oxidative N-demethylation of aryltriazenes in vitro 191
Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases. 190
Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice. 190
A phase II study of oral fluorouracil for gastrointestinal cancer 189
Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. 188
Psychosocial factors and breast cancer; a 6-year Italian follow-up study 187
Effects of isomeric aryldimethyl-triazenes on Lewis lung carcinoma growth and metastases in mice 187
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 186
Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension. 186
Neutral proteinase inhibitors and antimetastatic effects in mice. 185
Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins 183
Mechanism of the antimetastatic action of N-diazoacetylglycinamide in mice bearing Lewis lung carcinoma. 178
TPMT genotype and the use of thiopurines in pediatric inflammatory bowel disease. 177
Lysosomal enzyme inhibitors and antimetastatic activity in the mouse. 175
Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma 174
Antimetastatic effects of a leukocyte intracellular inhibitor of neutral proteases. 173
Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma 170
Repeated suicidal behaviour: Stressful life events and 5-HTTLPR geneticpolymorphism 169
Effects of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia. 168
Seasonal effects of rotational stress on Lewis lung carcinoma metastasis and T-lymphocyte subsets in mice 165
PHARMACOGENETIC OF ESCITALOPRAM AND MENTAL ADAPTATION TO CANCER IN PALLIATIVE CARE: REPORT OF 18 CASES 164
Restraint stress reduces the antitumor efficacy of cyclophosphamide in tumor-bearing mice 162
Some further characteristics of endogenous proteinase inhibitors. 161
Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry 159
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes. 155
Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells. 153
Stress, metastasi e curabilità dei tumori 143
Effects of N-diazoacetyl-glycine amide on the pool of 5-phosphoribosyl 1-pyrophosphate in Ehrlich ascites tumour cells. 143
DTIC e i suoi derivati: farmaci citotossici o antimetastatici? 143
Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM) 142
Synthesis of 1-aryl-3-formyl-3-methyltriazenes, potential metabolites of 1-aryl-3,3-dimethyltriazenes. 141
Mechanism of the antimetastatic action of dimethyltriazenes. 136
Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs. 134
Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing Lewis lung carcinoma. 133
Selective antimetastatic drugs (review). 133
Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. 133
Physiological regulation pf P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny 126
Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells 124
Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. 123
Toxicology and pharmacokinetic study of low doses of verapamil combined with doxorubicin 122
Melatonin administration in tumor bearing mice (intact or pinealectomized) in relation to stress, zinc, thymulin and IL-2 117
Survival time in mice bearing TLX5 lymphoma subjected to rotational stress and chemotherapy with CCNU 117
Infiltration of liver and brain by tumor cells in leukemik mice: prevention by dimethyltriazenes and cyclophosphamide. 116
Effects of the prolonged treatment with dacarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma 113
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastasis of non-small-cell lung cancer 111
Suppression of metastatic potential and up-regulation of gelatinases and uPA il LLC by protracted in vivo treatment with dacarbazine or razoxane 110
Physiscian\'s attitudes to and problems with truth-telling to cancer patients 109
Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice 109
Seasonal dependency of the effects of experimental stressors on tumor metastasis in ice bearing Lewis lung carcinoma 106
Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential 104
Melatonin and oxidative damage in mice liver induced by the prooxodant antitumor drug, adriamycin 98
Totale 13.807
Categoria #
all - tutte 42.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022739 0 0 0 132 5 84 43 38 106 110 48 173
2022/20231.226 115 125 81 155 154 266 5 91 155 9 57 13
2023/2024613 77 37 50 47 85 31 65 113 16 7 57 28
2024/20251.302 17 23 56 131 194 124 75 61 200 138 124 159
2025/20263.540 285 241 318 364 273 359 547 119 342 511 80 101
2026/2027619 96 250 268 5 0 0 0 0 0 0 0 0
Totale 13.807